Scientists make breakthrough in new drug for heart attack
Connect with us

Tech

Scientists make breakthrough in new drug for heart attack

Published

on

Scientists make breakthrough in new drug for heart attack

Scientists at the MDI Biological Laboratory and Novo Biosciences have identified a drug to restore heart muscle function following a heart attack.

Their research on the role of MSI-1436 in regenerating heart muscle tissue in zebrafish and mice was described in a paper in the peer-review journal, npj Regenerative Medicine.

Cardiovascular disease is the world’s leading killer, taking the lives of 17.5 million people annually, according to the World Health Organization, and disabling millions more. Currently, no drug exists to restore heart muscle function after a heart attack.

Read also: 7 things to look out for when purchasing a new laptop

“The potential impact of MSI-1436 is enormous,” MDI Biological Laboratory scientist Viravuth P. Yin, Ph.D., one of the paper’s authors, said. “If it shows similar results in humans, it will be a game-changer for patients who suffer a heart attack and/or are living with heart disease.”

The institution is seeking to move the drug into human clinical trials through a spinoff company, Novo Biosciences. The next step is to test the drug in pigs, the animal whose heart most closely resembles that of humans.

RipplesNigeria ….without borders, without fears

Click here to download the Ripples Nigeria App for latest updates

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now

Exit mobile version